What is Gabrielle Bender's NPI number?

Gabrielle Bender's National Provider Identifier (NPI) is 1952068512, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Gabrielle Bender's specialty?

Gabrielle Bender is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).

Where is Gabrielle Bender located?

Gabrielle Bender's practice location on file with NPPES is 5783 Wooster Pike, Medina, OH 44256-8816.

What is Gabrielle Bender's phone number?

The practice phone number listed in the NPPES registry for Gabrielle Bender is (330) 725-0569.

Does Gabrielle Bender accept Medicare?

Gabrielle Bender is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Gabrielle Bender's NPI active?

Yes — Gabrielle Bender's NPI (1952068512) is active in the NPPES registry as of the last update on 2025-12-17.

IndividualActiveAccepts Medicare

Gabrielle Bender, PA-C

NPI 1952068512 · Physician Assistant · Medina, OH

Gabrielle Bender, PA-C is a Physician Assistant provider in Medina, OH (NPI 1952068512).

Provider details

NPI number: 1952068512
Entity type: Individual
Primary specialty: Physician AssistantPhysician Assistants & Advanced Practice Nursing Providers
Credential: PA-C
Sex: Female
Sole proprietor: No
License: 50.008051RX (OH)

Practice location

5783 Wooster Pike

Medina, OH 44256-8816

Phone: (330) 725-0569

Street-level locationGet directions

More OH providers

Mailing address

5783 Wooster Pike

Medina, OH 44256-8816

Specialties & taxonomies

Physician AssistantPrimary363A00000XLicense 50.008051RX (OH)
Physician Assistants & Advanced Practice Nursing Providers

Enrolled with Medicare as Practitioner - Physician Assistant · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(75/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
4 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
2,068 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	678	$5
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	327	$73
Destruction of Precancer Skin Growth, 1 Growth17000	230	$38
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	179	$102
Biopsy of Related Skin Growth, First Growth11102	145	$64
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 12 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	165	92
Clobetasol Propionate	83	51
Triamcinolone Acetonide	75	66
Doxycycline Monohydrate	38	30
Apremilastbrand: Otezla	28	—
Fluorouracil	27	24
Ammonium Lactate	22	—
Mupirocin	18

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,894 across 95 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2021-11-18
Last updated: 2025-12-17
Certified: 2025-12-17

Frequently asked questions

What is Gabrielle Bender's NPI number?: Gabrielle Bender's National Provider Identifier (NPI) is 1952068512, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Gabrielle Bender's specialty?: Gabrielle Bender is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).
Where is Gabrielle Bender located?: Gabrielle Bender's practice location on file with NPPES is 5783 Wooster Pike, Medina, OH 44256-8816.
What is Gabrielle Bender's phone number?: The practice phone number listed in the NPPES registry for Gabrielle Bender is (330) 725-0569.
Does Gabrielle Bender accept Medicare?: Gabrielle Bender is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Gabrielle Bender's NPI active?: Yes — Gabrielle Bender's NPI (1952068512) is active in the NPPES registry as of the last update on 2025-12-17.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	678	$5
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	327	$73
Destruction of Precancer Skin Growth, 1 Growth17000	230	$38
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	179	$102
Biopsy of Related Skin Growth, First Growth11102	145	$64
Destruction of Skin Growth, 1-14 Growths

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

165

Clobetasol Propionate

Triamcinolone Acetonide

Doxycycline Monohydrate

Apremilastbrand: Otezla

—

Fluorouracil

Ammonium Lactate

—

Mupirocin

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,894 across 95 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments